Cite
HARVARD Citation
Smolen, J. et al. (2009). Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Annals of the rheumatic diseases. 68 (6), pp. 797-804. [Online].